|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$145
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
$723,348
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
|
4R44CA217587-02
|
$1,165,750
|
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
UCLA SPORE in Prostate Cancer
|
3P50CA092131-15S1
|
$1,162,609
|
|
REITER, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
SPORE in Genitourinary Cancer
|
3P50CA091846-15S1
|
$1,162,609
|
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Breast Cancer
|
3P50CA098131-16S1
|
$1,162,609
|
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
4R44CA224460-02
|
$1,111,364
|
|
DAUNCH, WILLIAM
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$43,778
|
Barr, Frederic
|
CCR (NCI)
|
|
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
|
3U01DK108328-04S2
|
$1,000,000
|
|
YUAN, YING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone
|
4R44CA224994-02
|
$749,974
|
|
NEDERLOF, MICHEL
|
QUANTITATIVE IMAGING SYSTEMS, LLC
|
|
Cellular Interactions with Thrombospondin
|
ZIA SC 009172
|
$734,023
|
$36,701
|
Roberts, David
|
CCR (NCI)
|
|
Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors
|
4R44CA217528-02
|
$710,496
|
|
SRINIVASAN, RAVI
|
ONCONANO MEDICINE, INC.
|
|
A real-time, cost-effective, accurate UV measurement and sun protection system to prevent and reduce the incidence of sunburn in high-risk consumers.
|
4R44CA224658-02
|
$686,491
|
|
MEITL, MATTHEW
|
WEARIFI, INC.
|
|
SPORE in Skin Cancer
|
3P50CA121973-10S2
|
$500,000
|
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$4,748
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Redox Mechanism Process of Angiogenesis and Wound Healing
|
ZIA BC 010898
|
$435,200
|
$87,040
|
Wink, David
|
CCR (NCI)
|
|
Multilevel Resilience Trajectories in the Transition to Cancer Survivorship
|
4UH3CA220642-02
|
$402,405
|
|
PARK, CRYSTAL
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133-04180
|
$390,015
|
$7,800
|
Linet, Martha
|
DCEG (NCI)
|
|
Circulating plasma tumor DNA as a biomarker for early stage breast cancer
|
7R01CA194024-03
|
$378,539
|
|
PARK, BEN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
3U24CA180803-05S1
|
$335,460
|
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Nitric Oxide as a Modifier of Oxidative Stress
|
ZIA SC 007281
|
$326,400
|
$65,280
|
Wink, David
|
CCR (NCI)
|
|
Cancer Therapy-induced Long-term Bone Marrow Injury
|
7R01CA122023-11
|
$308,813
|
|
ZHOU, DAOHONG
|
UNIVERSITY OF FLORIDA
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA013696-44S9
|
$250,000
|
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Studying the initiation, progression and therapy of lung cancer in mouse models
|
3R01CA131261-09S2
|
$249,999
|
|
MCMAHON, MARTIN
|
UNIVERSITY OF UTAH
|
|
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk
|
4R00CA207872-03
|
$248,995
|
|
RYSER, MARC
|
DUKE UNIVERSITY
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Physical Activity Platform to Improve Bone Health in Cancer Survivors
|
6R43CA224412-02
|
$224,098
|
|
SKINNER, CATHERINE
|
THRIVORS, INC.
|
|
Inflammation and cancer treatment
|
ZIA BC 010899
|
$217,600
|
$21,760
|
Wink, David
|
CCR (NCI)
|
|
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
|
3R44CA200186-03S1
|
$209,717
|
|
HUMBLET, VALERIE
|
COLLAGEN MEDICAL, LLC
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S7
|
$199,806
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-10S2
|
$188,884
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia
|
3R01CA213775-01A1S1
|
$160,000
|
|
DEBNATH, JAYANTA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Mechanisms of neuroinflammation in brain metastasis progression
|
3R01CA222405-01A1S1
|
$154,500
|
|
ZHANG, SIYUAN
|
UNIVERSITY OF NOTRE DAME
|
|
Cancer Center Support (CORE) Grant
|
3P30CA034196-33S1
|
$150,000
|
|
LIU, EDISON
|
JACKSON LABORATORY
|
|
Defining the urban-rural continuum and distinguishing rural differences to prevent tobacco use
|
3R21CA205589-02S1
|
$146,947
|
|
STILLMAN, FRANCES
|
NATIONAL OPINION RESEARCH CENTER
|
|
Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II
|
3R44CA203166-03S1
|
$136,623
|
|
ZINNEN, SHAWN
|
MBC PHARMA, INC.
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S2
|
$126,060
|
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-53S3
|
$125,000
|
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells
|
3R33CA212806-02S1
|
$121,845
|
|
ZILBERBERG, JENNY
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA014236-44S4
|
$119,106
|
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Targeting Epigenetic Circuits in B-Cell Lymphomas
|
3R35CA220499-01A1S1
|
$113,565
|
|
MELNICK, ARI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Chemical Biology of Nitroxyl (HNO)
|
ZIA BC 011190
|
$108,800
|
$43,520
|
Wink, David
|
CCR (NCI)
|
|
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics
|
3U24CA194215-03S1
|
$79,500
|
|
XU, HUA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations
|
3R33CA192980-03S2
|
$77,750
|
|
SALIPANTE, STEPHEN
|
UNIVERSITY OF WASHINGTON
|
|
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis
|
3R01CA177069-05S1
|
$75,000
|
|
SCHIEMANN, WILLIAM
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeted Epigenetic Therapy for Triple-Negative Breast Cancer
|
3R41CA203067-01A1S1
|
$74,751
|
|
ZHOU, MING-MING
|
PARKSIDE SCIENTIFIC, INC.
|
|
Therapeutic targeting of CD47 regulates tumor cell bioenergetics and mitophagy
|
3K22CA181274-03S1
|
$71,618
|
|
SOTO PANTOJA, DAVID
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Heart for this search: $1,049,071
|